General Information of the Compound
| Compound ID |
CP0382035
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-methyl-5-[2-[4-[[3-(1-methylsulfonylpiperidin-4-yl)phenyl]methyl]piperidin-1-yl]ethoxy]quinoline
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H39N3O3S
|
||||||||||||||||||
| Molecular Weight |
521.727
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc2c(OCCN3CCC(Cc4cccc(c4)C4CCN(CC4)S(C)(=O)=O)CC3)cccc2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H39N3O3S/c1-23-9-10-28-29(31-23)7-4-8-30(28)36-20-19-32-15-11-24(12-16-32)21-25-5-3-6-27(22-25)26-13-17-33(18-14-26)37(2,34)35/h3-10,22,24,26H,11-21H2,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
XPNIZGYNEMMEKJ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT01202, 5-hydroxytryptamine receptor 1B
Protein ID: PT00827, 5-hydroxytryptamine receptor 1D